Valirx Share Discussion Threads

[jasonpugh] 23/9/2020 11:50

Suzy keeps to her word..
When the data is ready they will release immediately.. this could be anytime..
Not only 07:00am but ANY time through trading day...
Be warned..if you sell... lockout!
DYOR

[stoneme] 23/9/2020 11:39

I think it is about to go thrusting past 50p. Buying is relentless, and no sellers

[jungmana] 23/9/2020 11:31

Stig- yes pyc will get 2 to 3% of revenues generated from val201. All we need now is success here.Val gets 97% or more

[hazelst] 23/9/2020 11:29

Where's that mug punter John smith? lol

[the stigologist] 23/9/2020 11:29

Worth laying out why this could be huge for PYC and arguably maybe even bigger and better for PYC than for VAL!

1. PYC have a FREE carried interest. We won't have to meet future costs of VAL201 (or VAL overheads) i.e. Trials costs/share dilution of Phase II/Phase III

2. Any VAL success in demonstrating SRC Inhibition approach may mean PYC can sell their SRC Inhibition modelling and simulation skills to other Companies looking to follow similar approach (maybe outside of Prostate Cancer as contract with VAL may have included a non-compete clause)

3. I believe Physiomics deliberately mentioned VAL201 in their August tweet because VAL have already approached them with regards to potentially engaging PYC to do modelling and simulation work on any future Phase II/III trial either for optimal dosing or potential combinations with potential Partner drugs?

[412069] 23/9/2020 11:10

Not enough shares for sale until Bown/Slater & Hargreaves & Co sell the mm’s will have to keep upping the bid it’s the only option.

[jassyb55] 23/9/2020 11:09

Guys, just remember the market cap of this company is so low compared to it's peers. It's fully funded, so need for a placing and its new strategy is to incorporate Pharma companies to help fund development of products.

[jungmana] 23/9/2020 11:00

Dam is about to burst, 50p+ coming :-)

[jusjusjus] 23/9/2020 10:59

46p being paid now!

[reidy66] 23/9/2020 10:48

We need to punch through 46p and hold it .

[jungmana] 23/9/2020 10:40

Tburns, not long to wait now. 150p would be about GBP 100 million market cap.

[tburns] 23/9/2020 10:36

That would be great Jungmana, can see todays highs being tested again shortly. We all know that good news on 201 is worth a lot more than 50p and have seen some mention 150p although that sounds toppy, although our market cap is so low compared to others who really knows. Only 5 trading days to find out and keep hold of your golden tickets.

[jungmana] 23/9/2020 10:30

Imo should see 50p today :-)

[tburns] 23/9/2020 10:19

Yes stoneme, they keep tying to push it down but buying keeps reversing it, can see 45-47p close today and through 50p tomorrow. GLA

[stoneme] 23/9/2020 10:17

Same pattern as yesterday. We know what happens later

[jungmana] 23/9/2020 09:19

I one hour we traded 10% of the stock in issue. Should go higher by afternoon

[412069] 23/9/2020 08:55

Read and weep JS.


Gainers for 4 days
EPIC Name Price Today Price Then Change Change %
VAL Valirx Plc 44 23.5 +20.50 87.23%

[jasonpugh] 23/9/2020 08:50

Physiomics is going well today as well.. wonder why 👍

[uknighted] 23/9/2020 08:49

ValiRx PLC

23 September 2020

VALIRX PLC

("ValiRx", the "Company" or the "Group")

Share Price Movement / Exercise of Warrant

London, UK 23 September 2020: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company, notes the recent movement in its share price and confirms as notified on 7 September 2020, it still expects to receive and notify the headline VAL 201 trial results by 30 September 2020 as stated in the half year results notified on 7 September 2020, extracts of which as set out below:-

"The Phase 1/2 clinical trial of VAL201 in the treatment of men with prostate cancer was closed to further recruitment on 27 January 2020, with recruitment standing at a total of 12 patients dosed across 5 cohorts. The dose escalation was carried out from 0.5 mg/kg up to 8 mg/kg with dosing being carried out once a week.

The trial considered the safety and tolerability of drug administration, alongside pharmacokinetics and disease impact. Although the COVID-19 pandemic lockdown initially cast concern on the time schedules for data verification processes, the project remains on track to release headline results within Q3 2020, which will provide basic details of safety, tolerability and disease impact. More detailed observations on the pharmacokinetics and complete summaries of patient demographics, biochemistry and study conduct will be available when the Clinical Study Report is completed in Q4 2020."

Following the placing announced on 23 July 2020 and the subsequent warrant exercises and block listing application announced on 19 August 2020 and the warrant update announced on 14 September 2020, the Company's current cash balance is circa GBP2 million.

[uknighted] 23/9/2020 08:47

JS I acquired my holding through the RTO!!

[bspgamer] 23/9/2020 08:37

Guys have a look at this also. EEE its about to start drilling for gold not far away from GGP on the 28th. 7 million market cap and 1.25 million in the bank. Also got huge assets in Georgia!!

[nico115] 23/9/2020 08:32

Don't get angry Just smile that he is 700pct wrong He makes me laugh as he is long at 70p I'm old form so needs 850p to break even Kills him that many are in at 7p !! Lol

[tidy 2] 23/9/2020 08:27

PYC free carried on Val hTTps://twitter.com/stockonomist/status/1308656227648405505?s=21